FDA is issuing a draft guidance on the
process for formally resolving scientific and procedural disputes
in CDER and CBER that cannot be resolved at the division level. The
draft guidance describes procedures for formally appealing such
disputes to the office or center level and for submitting
information to assist center officials in resolving the issue(s)
presented. The draft guidance provides information on how the
Agency will interpret and apply provisions of the existing
regulations regarding internal Agency review of decisions (sections
10.75) and dispute resoluton during the IND....
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.